Defining "aging research" as a field can be an elusive task. "It's difficult to wrestle this down to specific disciplines because it is so broad," says Daniel Perry, executive director of the Alliance for Aging Research (AAR), a nonprofit organization based in Washington, D.C. "I believe that the most important research is going to be done in areas where you never hear the word aging. A lot of science that adds to our understanding of aging goes by other names." William A. Haseltine, cha
 |
William A. Haseltine, chairman and CEO of Human Genome Sciences Inc. in Rockville, Md., comments, "We're now in the beginning stages of a major revolution of research and understanding of aging, not of the aging process itself, but what to do about it. A major thrust of medical research, especially finding new ways to treat and cure disease, will be directed at the problems of the aging. There's been a ...
Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.
View this Issue
Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and drug discovery.
Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.
In this webinar, Linghua Wang and Jeremy Goecks will talk about technology that enables new approaches for a better understanding of tumors on a cellular, spatial, and environmental level.
Explore how researchers use organoids to understand tissue regeneration and develop novel therapies.
Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery. Company also announces key accreditations in recognition of excellence in data security, AI innovation, and commitment to continuous improvement.
Partnership complements Sapient’s mass spectrometry-based proteomics services, extends multi-omics solutions, and will enable development of NULISAseq™ assays under regulated guidance
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of Vericheck ddPCR™ Empty-Full Capsid Kits for adeno-associated virus (AAV) serotypes 2 and 8, enabling determination of capsid titer, genome titer, and percentage of full capsids in purified or unpurified (crude lysate) samples.
Tailored nucleic acid extraction and amplification methods help scientists overcome the challenges of detecting Mycoplasma contamination in advanced therapy medicinal products.
